316 related articles for article (PubMed ID: 32293530)
21. Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study.
Lew PH; Rahman MT; Safii SH; Baharuddin NA; Bartold PM; Sockalingam S; Kassim NLA; Vaithilingam RD
BMC Oral Health; 2021 Jul; 21(1):360. PubMed ID: 34284769
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
[TBL] [Abstract][Full Text] [Related]
23. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.
Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
Arthritis Res Ther; 2017 Sep; 19(1):219. PubMed ID: 28962582
[TBL] [Abstract][Full Text] [Related]
24. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the immune feature of ACPA-negative rheumatoid arthritis and the clinical value of matrix metalloproteinase-3.
Liang Z; Wang N; Shang L; Wang Y; Feng M; Liu G; Gao C; Luo J
Front Immunol; 2022; 13():939265. PubMed ID: 35967336
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
[TBL] [Abstract][Full Text] [Related]
28. Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity.
Guan SZ; Yang YQ; Bai X; Wang Y; Feng KQ; Zhang HJ; Dong M; Yang HW; Li HQ
Ann Clin Lab Sci; 2019 Jan; 49(1):57-62. PubMed ID: 30814078
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
[TBL] [Abstract][Full Text] [Related]
30. ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.
Bondt A; Hafkenscheid L; Falck D; Kuijper TM; Rombouts Y; Hazes JMW; Wuhrer M; Dolhain RJEM
Ann Rheum Dis; 2018 Aug; 77(8):1130-1136. PubMed ID: 29615411
[TBL] [Abstract][Full Text] [Related]
31. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture.
Cheng TT; Yu SF; Su FM; Chen YC; Su BY; Chiu WC; Hsu CY; Chen JF; Ko CH; Lai HM
Arthritis Res Ther; 2018 Jan; 20(1):16. PubMed ID: 29382355
[TBL] [Abstract][Full Text] [Related]
32. Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
Kastbom A; Roos Ljungberg K; Ziegelasch M; Wetterö J; Skogh T; Martinsson K
Clin Exp Immunol; 2018 Dec; 194(3):391-399. PubMed ID: 30136282
[TBL] [Abstract][Full Text] [Related]
33. Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.
Boer AC; Boonen A; van der Helm van Mil AHM
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):987-996. PubMed ID: 29266813
[TBL] [Abstract][Full Text] [Related]
34. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
35. An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients.
Martínez-Estupiñán L; Hernández-Flórez D; Janta I; Ovalles-Bonilla JG; Nieto JC; González-Fernández CM; Del Río T; Monteagudo I; López-Longo FJ; Naredo E; Valor L
Clin Exp Rheumatol; 2018; 36(1):88-93. PubMed ID: 28850020
[TBL] [Abstract][Full Text] [Related]
36. Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.
Sohrabian A; Mathsson-Alm L; Hansson M; Knight A; Lysholm J; Cornillet M; Skriner K; Serre G; Larsson A; Weitoft T; Rönnelid J
Ann Rheum Dis; 2018 Sep; 77(9):1345-1353. PubMed ID: 29895567
[TBL] [Abstract][Full Text] [Related]
37. Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.
Lee JY; Choi IA; Kim JH; Kim KH; Lee EY; Lee EB; Lee YM; Song YW
BMC Musculoskelet Disord; 2015 Aug; 16():190. PubMed ID: 26265263
[TBL] [Abstract][Full Text] [Related]
38. Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
Joo YB; Park YJ; Park KS; Kim KJ
Clin Rheumatol; 2019 Sep; 38(9):2423-2432. PubMed ID: 31049760
[TBL] [Abstract][Full Text] [Related]
39. Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk.
Martinsson K; Roos Ljungberg K; Ziegelasch M; Cedergren J; Eriksson P; Klimovich V; Reckner Å; Griazeva I; Sjöwall C; Samoylovich M; Skogh T; Wetterö J; Kastbom A
Rheumatology (Oxford); 2020 May; 59(5):979-987. PubMed ID: 31504979
[TBL] [Abstract][Full Text] [Related]
40. Circulating IFN-γ producing CD4+ T cells and IL-17A producing CD4+ T cells, HLA-shared epitope and ACPA may characterize the clinical response to therapy in rheumatoid arthritis patients.
Alvandpur N; Tabatabaei R; Tahamoli-Roudsari A; Basiri Z; Behzad M; Rezaeepoor M; Roshanaei G; Hajilooi M; Solgi G
Hum Immunol; 2020 May; 81(5):228-236. PubMed ID: 32107036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
